Keating Financial Advisory Services’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.79K Buy
77
+23
+43% +$2.71K ﹤0.01% 1266
2026
Q2
$5.76K Sell
54
-3
-5% -$363 ﹤0.01% 1481
2026
Q1
$9.32K Buy
57
+22
+63% +$3.38K ﹤0.01% 1164
2025
Q4
$6.09K Buy
+35
New +$6.39K ﹤0.01% 1230

Other funds holding INSM

Keating Financial Advisory Services's INSM Position: Q3 2026 in Review

Keating Financial Advisory Services increased its Insmed (INSM) stake by 43% in Q3 2026, buying an estimated $2.71K and bringing the position to 77 shares worth $8.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Keating Financial Advisory Services first reported a position in INSM in Q4 2025 and has held it in 4 quarters since. The position peaked at $9.32K in Q1 2026. 695 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Keating Financial Advisory Services held 77 shares of Insmed worth $8.79K as of Q3 2026.
  • Keating Financial Advisory Services bought 23 Insmed shares in Q3 2026, an estimated $2.71K.
  • Insmed made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q3 2026, its #1266 holding.
  • Keating Financial Advisory Services first reported a position in Insmed in Q4 2025 and has held it in 4 quarters since.
  • Keating Financial Advisory Services's Insmed position peaked at $9.32K in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Keating Financial Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.